U.S. Beverage Stock News

Eagle Materials (EXP) has been under pressure recently, with the stock showing declines over the past week, month, and past 3 months. That pullback is prompting closer attention to the company’s current fundamentals. See our latest analysis for Eagle Materials. At a share price of US$186.43, Eagle Materials has seen recent momentum fade, with a 30-day share price return of 19.04% and a 1-year total shareholder return of 9.73%, while the 3 and 5-year total shareholder returns of 39.28% and...

If you are looking at Jefferson Capital and wondering whether the recent price offers value or a value trap, you will want to see how the current share price stacks up against a few different valuation checks. The stock last closed at US$20.36, with returns of a 6.4% decline over 7 days, a 9.4% decline over 30 days and a 7.9% decline year to date, which can change how investors think about both its potential upside and its risk. Recent coverage around Jefferson Capital has focused on its...

If you are wondering whether Array Technologies is starting to look like value at around US$6.80 per share, you are not alone. That question sits at the heart of this review. The stock has had a mixed run, with a 4.8% decline over the last 7 days, a sharper 41.4% decline over the last 30 days and a 29.8% decline year to date. Yet it still shows a 12.2% return over the last 1 year against much larger pullbacks of 61.8% over 3 years and 77.1% over 5 years. Recent coverage of Array Technologies...

Antero Midstream recently reported past fourth-quarter 2025 earnings that exceeded analyst expectations and completed the US$400,000,000 sale of its Utica Shale midstream assets to affiliates of Natural Resources, Inc. and Northern Oil and Gas, Inc. Alongside this, Senior Vice President and Chief Accounting Officer Sheri Pearce sold 14,000 shares, offering investors additional context on insider activity and capital allocation following the asset sale. With the Utica Shale asset sale now...

Recently, The Chefs’ Warehouse outlined its resilience plan amid economic and geopolitical uncertainty, highlighting ongoing integration of Hardie’s, facility expansions in Texas and the Middle East, and efforts to improve supply chain reliability. The company also underscored increasing use of AI and digital tools to sharpen sales execution and enhance the ordering experience for its restaurant customers. Next, we’ll examine how this push into AI-driven sales tools and operational expansion...

Wondering if Diversified Energy is priced fairly today, or if the market is missing something that you can still take advantage of? The shares last closed at US$14.44, with returns of 9.5% over the past 30 days and 32.0% over the past year. However, the 3-year and 5-year returns of negative 23.0% and negative 47.6% show a much tougher longer term picture. Recent coverage around Diversified Energy has focused on its position in the US energy sector and how its business model responds to...

If you are wondering whether Mid-America Apartment Communities is priced attractively right now, the key question is how its current share price lines up against what the business might be worth. The stock closed at US$127.75 recently, with returns of a 5.0% decline over 7 days, a 6.4% decline over 30 days, an 8.2% decline year to date, and a 17.6% decline over the past year, which will shape how many investors view its potential and risk today. Recent coverage around Mid-America Apartment...

Radware (NasdaqGS:RDWR) is drawing fresh attention after launching a cloud-based Web DDoS Protection service for encrypted traffic. The service is designed to block sophisticated layer 7 attacks without SSL certificate sharing or traffic decryption. See our latest analysis for Radware. That product launch comes as Radware’s share price sits at US$25.6, with a 90 day share price return of 7.74% and a 1 year total shareholder return of 21.96%. This suggests momentum has been building over the...

In early March 2026, Bank of America Securities initiated coverage of Ligand Pharmaceuticals, emphasizing its royalty-focused business model, diversified portfolio of more than 100 assets, and reaffirmed fiscal 2026 earnings and sales guidance. This coverage spotlighted Ligand’s capital-and-technology partnering approach, which aims to generate high-margin royalty streams across 12 major commercial-stage therapies while limiting traditional biopharma operating risks. Next, we’ll examine how...

MARA Holdings, Inc. has already reported full-year 2025 results, showing sales rising to US$907.09 million from US$656.38 million, while swinging from net income of US$541.25 million to a net loss of US$1,311.48 million and a basic loss per share from continuing operations of US$3.69. At the same time, options traders have been aggressively buying calls ahead of the next earnings report and the company’s push into AI infrastructure, signaling intense speculation around how this business...

Upstart Holdings (NasdaqGS:UPST) plans to apply for a US national bank charter, establishing Upstart Bank, N.A. The company intends to file applications with the OCC and FDIC, and seek Federal Reserve approval to become a bank holding company. The move would position Upstart to operate as an insured national bank with direct access to consumer deposits. For investors tracking NasdaqGS:UPST, this banking push comes after a difficult stretch for the stock. Shares recently closed at $25.76,...

Red Rock Resorts (RRR) shares are in focus after the company exceeded fourth-quarter 2025 earnings and revenue estimates, and its board approved a cash dividend of $0.26 per share. See our latest analysis for Red Rock Resorts. Despite a recent soft patch, with a 30 day share price return of a 13.6% decline and an 8.4% decline year to date at US$57.71, Red Rock Resorts still carries a 1 year total shareholder return of 42.9% and a 5 year total shareholder return of 110.7%. This suggests longer...

Natera (NasdaqGS:NTRA) has launched Zenith Genomics, a next generation whole genome sequencing assay for rare disease detection. The assay is being introduced in partnership with MyOme, with exclusive collaboration around genome wide rare disease diagnostics. Zenith Genomics integrates advanced methylation analysis with DNA sequencing to address difficult diagnostic questions in rare conditions. The launch and supporting data are being presented at a leading medical genetics conference,...

MGM Resorts International (MGM) is back in the spotlight as investors look ahead to its appearance at the J.P. Morgan Gaming, Lodging, Restaurant and Leisure Management Access Forum on March 12, 2026. See our latest analysis for MGM Resorts International. At a share price of US$36.30, MGM Resorts International has seen modestly weaker short term share price returns, with a 30 day share price return of a 2.84% decline and a 1 year total shareholder return of 20.36% showing stronger longer term...

Stryker (SYK) is back in focus after recent share price moves, with the stock down over the past week, month and past 3 months as investors reassess this large medical technology name. See our latest analysis for Stryker. Although the recent 1-day, 7-day and 3-month share price returns have been negative, Stryker’s 3-year and 5-year total shareholder returns of 26.14% and 53.80% show the longer term picture has been more favorable. This suggests recent momentum is fading rather than forming a...

WEBTOON Entertainment (WBTN) shares are in focus after the company paired modest 2025 revenue growth with a larger net loss and a cautious Q1 2026 outlook, prompting investors to reassess near term expectations. See our latest analysis for WEBTOON Entertainment. Those Q4 losses, cautious Q1 2026 guidance and the recent ESOP related shelf registration have gone hand in hand with softer sentiment. The share price is down 31.79% year to date and the 30 day share price return of 22.33% has pulled...

If you are wondering whether CRH is priced attractively right now, its recent share performance and fundamentals raise some useful questions about value that are worth unpacking. The stock closed at US$99.73, with a 10.2% decline over the last 7 days and a 22.8% decline over 30 days, even though the 1 year return is 7%, the 3 year return is 109.1%, and the 5 year return is 136.5%. Recent coverage has focused on CRH's role in the materials sector and how sentiment has shifted around companies...

BXP (BXP) has set up a broad capital-raising toolkit, filing new shelf registrations across multiple securities and a US$1b at-the-market common stock program, while also withdrawing a planned US$600m offering. See our latest analysis for BXP. The new capital program lands after a weak patch for the stock, with a 30 day share price return of 20.23% decline and a year to date share price return of 22.25% decline. At the same time, the 3 year total shareholder return of 17.14% suggests longer...

With no single headline event driving attention today, Black Hills (BKH) is drawing interest as investors reassess this regulated electric and natural gas utility company’s recent share performance and fundamental profile. See our latest analysis for Black Hills. At a share price of US$70.65, Black Hills has had a soft patch recently, with a 7 day share price return of negative 4.9% and a 30 day share price return of negative 2.4%. However, its 1 year total shareholder return of 24.2% points...

Polaris recently gained attention as Wells Fargo began covering the stock with an Equal-Weight rating, while the company also confirmed plans to sell its Indian motorcycle brand to Carolwood in the first quarter of 2026. Together with Polaris’s inclusion in the Russell 1000 ETF, these moves highlight a shift toward refocusing its portfolio and potentially broadening its investor base. Next, we’ll explore how Polaris’s planned divestiture of the Indian motorcycle brand could influence the...

Praxis Precision Medicines (PRAX) is back in focus after Driehaus Capital Management committed an additional 432,510 shares, a reported US$80.54 million, alongside fresh FDA submissions for ulixacaltamide and relutrigine. See our latest analysis for Praxis Precision Medicines. The 2.16% 1 day share price return, against a 5.34% 30 day decline and 12.86% 90 day gain, points to choppy but still positive momentum. A very large 1 year total shareholder return above 7x underlines how much...

If you are wondering whether eBay's share price still offers value after a strong run, looking closely at what you are paying for the underlying business becomes crucial. The stock last closed at US$90.00, with returns of 3.4% year to date and 42.7% over the past year, while the last 7 days showed a 3.3% decline and the last 30 days a 2.9% gain. Recent headlines have focused on eBay's position in the broader e commerce space and how it is refining its marketplace model to stay relevant with...

This article explores whether Salesforce, trading at around US$199 per share, may represent a bargain or a fair price for long term investors by examining what the current market valuation might imply. The stock has seen mixed returns, with a 1% decline over the last 7 days, a 3% gain over the last 30 days, and year to date and 1 year returns of 21.4% and 26.2% declines respectively, while the 3 year and 5 year returns sit at 7.7% and a 3.7% decline. Recent coverage around Salesforce has...

Why Global Net Lease has investors taking a closer look Global Net Lease (GNL) has been drawing fresh attention after recent share price moves, with the stock last closing at US$9.45 and showing mixed returns over the past month and past 3 months. See our latest analysis for Global Net Lease. Set against a 7.14% year to date share price return and a 33.78% total shareholder return over the past year, the recent pullback over the last month suggests momentum has cooled slightly after a...